Progress-EXS sponsors Investors Forum at Dutch Life Sciences Conference

news-releasesProgress Executive Services (Progress-EXS)

November 11th 2019

Hoofddorp, The Netherlands: – Strategic life sciences consultancy Progress Executive Services (Progress-EXS) is sponsoring the Investors Forum of the upcoming Dutch Life Sciences (DLS) Conference in Oegstgeest, The Netherlands.

The Investors Forum will provide young companies and start-ups with the opportunity to pitch for equity capital or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities.

Gateway to investors

The forum will form a centerpiece of the upcoming DLS conference on November 28, providing platform for entrepreneurs from industry and academia to business strategy, technology direction and capital-raising plan to venture capitalists, corporate/regional investment funds as well as representatives from university Technology Transfer departments.

Prior to the event, companies will be invited to participate in a number of dry-run presentations to gain feedback and get advice. The winning presentation will be rewarded with the Progress Investors Forum Prize; a ticket for a national or international partnering event with a total value of EUR 2,500. This will provide a gateway for the winners to reach the strategic audience of their choice anywhere in the world.

About Progress-EXS

Headquartered at Hoofddorp in The Netherlands, Progress Executive Services (Progress-EXS) is the high-level consultancy arm of Progress-PME, providing C-suite strategic advice and high-level management services to international customers in the life sciences industries.

Progress-EXS was founded to act as a key partner for executives within pharmaceutical, biotechnology, healthcare and other life science organizations, supporting them with their decision-making processes and identifying strategic and operational gaps that place products, delivery and quality at risk.

Progress-EXS principally supports its clients with interim senior management and consultancy services, relying on a wide network of consultants and senior interim executives possessing deep experience of top level management in the life science and pharmaceutical companies industry to offer specialized executive-focused advice and services. These cover strategic and business-critical aspects such as manufacturing efficiency, quality, business development and management of projects, processes and programs.

It has also developed targeted products and tools such as its validated license-to-operate GMP compliance program and time-to-market CMC Quickscans.

Further information at: https://www.progress-exs.com

About Progress-PME

Progress-PME is an independent consultancy company with customers in the pharmaceutical and biotechnology industries and in the healthcare sector. It operates internationally, supplying project management, engineering, CMC, validation Lean/OPex and quality assurance services.

Progress-PME’s mission is to excel in supporting clients to realize their business goals, harnessing broad knowledge and experience, combined with focus and flexibility to guarantee high value services and projects and multi-disciplinary progress. Progress-PME offers general services in eight fields: project management, a specialized Quickscan & GAP analysis services helping companies into new markets or products, training, hospital pharmacy support, biobanking, and environmental management.

The company also offers management services covering fields such as Quality Management, Lean Six Sigma performance improvement, Chemistry Manufacturing and Control (CMC) for new pharmaceutical products, engineering and facilities support.

Founded in 1999, Progress-PME and its Executive Services subsidiary Progress EXS are privately-owned companies.

Further information at: https://www.progress-pme.com/home.html

About Dutch Life Science Conference 2019

The Dutch Life Sciences Conference is an annual meeting hosted by Leiden Bio Science Park in The Netherlands that aims to stimulate discussions and interactions between business executives, R&D specialists, policy makers and investors from the, focusing on trends and developments in the domestic and international life sciences sectors.

Themed ‘Accelerating change in healthcare’ the 15^th DLS meeting is a one-day event on November 28, 2019, staged at the CORPUS Congress Centre in Oegstgeest, near Leiden.

The programme will feature numerous plenary and parallel sessions, with speakers including astronaut Dr. André Kuipers, Frame Therapeutics CEO Ronald Plasterk, MiLabs CEO and founder Prof. Freek Beekman, and Bedrocan CEO Tjalling Erkelens).

The conference will also feature the Investors Forum, active networking possibilities and an information exchange, as well as the awards for the Venture Challenge.

Topics for discussion in 2019 include the impact of biomedical imaging on patients, personalized healthcare in oncology, guidance on successful IPOs, mergers and acquisitions, and the applications of cannabinoids in pharma and nutrition.

The Dutch Life Sciences Conference project is organised by Iventus with further information at: https://www.dutchlifesciences.com